XTL BIOPHARMACEUTICALS LTD | CIK:0001023549 | 3

  • Filed: 3/15/2018
  • Entity registrant name: XTL BIOPHARMACEUTICALS LTD (CIK: 0001023549)
  • Generator: Ez-XBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/0001213900-18-003028-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/xtlb-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001023549
  • Open this page in separate window: Click
  • ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory

    n.Loss per share:

     

    Basic loss per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number of ordinary shares outstanding during the period, less treasury shares.

     

    For the diluted earnings per share calculation, the weighted average number of shares outstanding during the year is adjusted for the average number of shares that are potentially issuable in connection with employee share-based payment and warrants,using the treasury stock method. If the inclusion of potentially issuable shares would decrease loss per share, the potentially issuable shares are excluded from the weighted average number of shares outstanding used to calculate diluted earnings per share